The smartNTx Trial: A Prospective, Randomized Controlled Trial (RCT) to Investigate Additional Interventional Telemedical Management Versus Standard Aftercare in Kidney Transplant Recipients (KTR)

NAActive, not recruitingINTERVENTIONAL
Enrollment

384

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

August 30, 2026

Conditions
Kidney Transplant RejectionKidney Transplant Failure
Interventions
COMBINATION_PRODUCT

Additional interventional telemedical management

Predefined additional telemedical management including regular telemedicine visits and automatic data transfer (e.g. vital signs, well-being, medication plan laboratory data and chat) between the patient at home and KTC through a certified smartphone application.

Trial Locations (2)

10117

Charité Universitätsmedizin Berlin, Berlin

Unknown

University Hospital Essen, Essen

All Listed Sponsors
collaborator

Charite University, Berlin, Germany

OTHER

collaborator

University Hospital, Essen

OTHER

lead

University of Erlangen-Nürnberg Medical School

OTHER